Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2005

Intellectual Property 101

George B. Stefano, J. Patrick Finn III

Med Sci Monit 2005; 11(11): ED7-7 :: ID: 430274


Sometimes what we don’t know really can hurt us. After many discussions with colleagues around the world, Medical Science Monitor will start to carry information, which may help us realize the significance of intellectual property and how we may protect it. This information, which is general in nature given our global audience, may vary in its interpretation and implementation, depending on your country. However, it will cause us all to think about the signifi cance of what we are doing in advancing knowledge by being creative.
Regardless of what country you are in, there is a mechanism to protect intellectual property. In general, intellectual property can be defi ned as any useful technology, e.g., a drug or treatment protocol that you invented that is novel and not obvious. Note, a potential inventor should keep information relating to the intellectual property confi dential since making it public can result in a loss of potential intellectual property rights. This means that in order to protect your intellectual property you should avoid disclosing it to others both orally and in writing before it is protected. The exceptions to this rule are that you may discuss it with your employer (e.g., a university/ company/hospital offi cial), any co-inventors, and your or your employer’s lawyer. It is important to remember that any public disclosure without, for example, fi ling a patent application can result in giving away the technology.
If you plan to discuss this technology with an interested party, a confi dentiality agreement should
be in place whereby the party agrees not to use your technology except for purposes of evaluation and agrees to keep it confi dential. One major consideration regarding new intellectual property is whether the technology is important. Does it have the potential to generate revenue for its owners or provide signifi cant help to others? Many technologies are patentable (e.g., novel and non-obvious), but few generate a revenue stream. It is important to have discussions with experts that can help you make this determination. In some cases, individuals can lose the ability to obtain protection by publishing their work without even realizing that their publication discloses new intellectual property that may have monetary advantages. In other words, an individual may lose the ability to obtain patent protection simply by not communicating the technology to the appropriate experts.To help provide researchers and clinicians with valuable intellectual property information, Index Copernicus can be used to determine what types of intellectual properties exist, e.g., patents. Index Copernicus also can be used to find legal mechanisms for obtaining protection and experts who may assist in rendering legal advice regarding your technology. If you don’t know what you have – you don’t have it. Dr. Stefano is Vice Chair of the Board of Directors of the Research Foundation of the State University of New York and member of the State University of New York Patent Committee. J. Patrick Finn III, Ph.D, J.D. is a patent attorney at Fish & Richardson, P.C. and contributed to this article. One focus of his practice is obtaining world-wide patent protection for universities as well as biotech and medical device clients.

Keywords: Intellectual Property, Information Services, Biotechnology, Patents as Topic

Add Comment 0 Comments

731 1


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

08 Jun 2023 : Clinical Research  

Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...

Med Sci Monit In Press; DOI: 10.12659/MSM.940134  

08 Jun 2023 : Clinical Research  

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940124  

08 Jun 2023 : Clinical Research  

Burden of COVID-19 on Mental Health of Resident Doctors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940208  

08 Jun 2023 : Clinical Research  

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...

Med Sci Monit In Press; DOI: 10.12659/MSM.940251  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750